<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36004306</PMID><DateRevised><Year>2022</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1756-283X</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Therapeutic advances in gastroenterology</Title><ISOAbbreviation>Therap Adv Gastroenterol</ISOAbbreviation></Journal><ArticleTitle>Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>17562848221118403</StartPage><MedlinePgn>17562848221118403</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17562848221118403</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/17562848221118403</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Prolonged symptoms after COVID-19 are an important concern due to the large numbers affected by the pandemic.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">To ascertain the frequency of gastrointestinal (GI) manifestations as part of long GI COVID.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">A systematic review and meta-analysis of studies reporting GI manifestations in long COVID was performed.</AbstractText><AbstractText Label="DATA SOURCES AND METHODS" NlmCategory="UNASSIGNED">Electronic databases (Medline, Scopus, Embase, Cochrane Central Register of Controlled Trials, and Web of Science) were searched till 21 December 2021 to identify studies reporting frequency of GI symptoms in long COVID. We included studies reporting overall GI manifestations or individual GI symptoms as part of long COVID. We excluded pediatric studies and those not providing relevant information. We calculated the pooled frequency of various symptoms in all patients with COVID-19 and also in those with long COVID using the inverse variance approach. All analysis was done using R version 4.1.1 using packages 'meta' and 'metafor'.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 50 studies were included. The frequencies of GI symptoms were 0.12 [95% confidence interval (CI), 0.06-0.22, <i>I</i> <sup>2</sup>&#x2009;=&#x2009;99%] and 0.22 (95% CI, 0.10-0.41, <i>I</i> <sup>2</sup>&#x2009;=&#x2009;97%) in patients with COVID-19 and those with long COVID, respectively. The frequencies of abdominal pain, nausea/vomiting, loss of appetite, and loss of taste were 0.14 (95% CI, 0.04-0.38, <i>I</i> <sup>2</sup>&#x2009;=&#x2009;96%), 0.06 (95% CI, 0.03-0.11, <i>I</i> <sup>2</sup>&#x2009;=&#x2009;98%), 0.20 (95% CI, 0.08-0.43, <i>I</i> <sup>2</sup>&#x2009;=&#x2009;98%), and 0.17 (95% CI, 0.10-0.27, <i>I</i> <sup>2</sup>&#x2009;=&#x2009;95%), respectively, after COVID-19. The frequencies of diarrhea, dyspepsia, and irritable bowel syndrome were 0.10 (95% CI, 0.04-0.23, <i>I</i> <sup>2</sup>&#x2009;=&#x2009;98%), 0.20 (95% CI, 0.06-0.50, <i>I</i> <sup>2</sup>&#x2009;=&#x2009;97%), and 0.17 (95% CI, 0.06-0.37, <i>I</i> <sup>2</sup>&#x2009;=&#x2009;96%), respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">GI symptoms in patients were seen in 12% after COVID-19 and 22% as part of long COVID. Loss of appetite, dyspepsia, irritable bowel syndrome, loss of taste, and abdominal pain were the five most common GI symptoms of long COVID. Significant heterogeneity and small number of studies for some of the analyses are limitations of the systematic review.</AbstractText><CopyrightInformation>&#xa9; The Author(s), 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choudhury</LastName><ForeName>Arup</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tariq</LastName><ForeName>Raseen</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jena</LastName><ForeName>Anuraag</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vesely</LastName><ForeName>Elissa Kinzelman</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Siddharth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Biomedical Informatics, University of California San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanna</LastName><ForeName>Sahil</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7619-8338</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Vishal</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-2472-3409</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh 160012, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Therap Adv Gastroenterol</MedlineTA><NlmUniqueID>101478893</NlmUniqueID><ISSNLinking>1756-283X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">abdominal pain</Keyword><Keyword MajorTopicYN="N">diarrhea</Keyword><Keyword MajorTopicYN="N">gastrointestinal symptoms</Keyword><Keyword MajorTopicYN="N">long COVID haulers</Keyword><Keyword MajorTopicYN="N">nausea</Keyword><Keyword MajorTopicYN="N">post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">vomiting</Keyword></KeywordList><CoiStatement>Competing interests: The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>25</Day><Hour>2</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36004306</ArticleId><ArticleId IdType="pmc">PMC9393939</ArticleId><ArticleId IdType="doi">10.1177/17562848221118403</ArticleId><ArticleId IdType="pii">10.1177_17562848221118403</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nabavi N. Long covid: how to define it and how to manage it. BMJ 2020; 370: m3489.</Citation><ArticleIdList><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6
October
2021, https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (2021, accessed 23 March 2022).</Citation></Reference><Reference><Citation>
CDC. Long COVID or post-COVID conditions, https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html (2021, accessed 23 March 2022).</Citation></Reference><Reference><Citation>Cheung KS, Hung IFN, Chan PPY, et al.. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology 2020; 159: 81&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194936</ArticleId><ArticleId IdType="pubmed">32251668</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar-M P, Mishra S, Jha DK, et al.. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis. Hepatol Int 2020; 14: 711&#x2013;722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7335221</ArticleId><ArticleId IdType="pubmed">32623633</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni W, Yang X, Yang D, et al.. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care 2020; 24: 422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7356137</ArticleId><ArticleId IdType="pubmed">32660650</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med 2021; 9: 129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Balduzzi S, R&#xfc;cker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 2019; 22: 153&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10231495</ArticleId><ArticleId IdType="pubmed">31563865</ArticleId></ArticleIdList></Reference><Reference><Citation>Suurmond R, van Rhee H, Hak T. Introduction, comparison, and validation of meta-essentials: a free and simple tool for meta-analysis. Res Synth Methods 2017; 8: 537&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5725669</ArticleId><ArticleId IdType="pubmed">28801932</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuritz SJ, Landis JR, Koch GG. A general overview of Mantel-Haenszel methods: applications and recent developments. Annu Rev Public Health 1988; 9: 123&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pubmed">3288229</ArticleId></ArticleIdList></Reference><Reference><Citation>Munn Z, Moola S, Lisy K, et al.. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc 2015; 13: 147&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">26317388</ArticleId></ArticleIdList></Reference><Reference><Citation>Adame MJ, Nadda KM, Seashore J. Late sequelae of COVID-19 infection in patients without comorbidities. Am J Respir Crit Care Med 2021; 203: A3821.</Citation></Reference><Reference><Citation>Akinci Ozyurek B, Sahin Ozdemirel T, Akkurt ES, et al.. What are the factors that affect post COVID 1st month&#x2019;s continuing symptoms? Int J Clin Pract 2021; 75: e14778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646622</ArticleId><ArticleId IdType="pubmed">34478600</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya JM, Rojas M, Salinas ML, et al.. Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev 2021; 20: 102947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Areekal B, Sukumaran ST, Andrews AM, et al.. Persistence of symptoms after acute COVID-19 infection-an experience from a tertiary care centre in South India. J Clin Diagn Res 2021; 15: LC05&#x2013;LC08.</Citation></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al.. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 2021; 6: 100122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackett JW, Li J, Jodorkovsky D, et al.. Prevalence and risk factors for gastrointestinal symptoms after recovery from COVID-19. Neurogastroenterol Motil 2022; 34: e14251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646904</ArticleId><ArticleId IdType="pubmed">34468069</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair JE, Gotimukul A, Wang F, et al.. Mild to moderate COVID-19 illness in adult outpatients: characteristics, symptoms, and outcomes in the first 4 weeks of illness. Medicine (Baltimore) 2021; 100: e26371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8213280</ArticleId><ArticleId IdType="pubmed">34128896</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttery S, Philip KEJ, Williams P, et al.. Patient symptoms and experience following COVID-19: results from a UK-wide survey. BMJ Open Respir Res 2021; 8: e001075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8572361</ArticleId><ArticleId IdType="pubmed">34732518</ArticleId></ArticleIdList></Reference><Reference><Citation>Calogero C, Chauhan K, Chalikonda, et al.. S3282 evaluation of delayed gastric emptying in patients with a prior SARS-CoV-2 infection: a single center review. Am J Gastroenterol 2021; 116: S1352.</Citation></Reference><Reference><Citation>Carrillo-Garcia P, Garmendia-Prieto B, Cristofori G, et al.. Health status in survivors older than 70 years after hospitalization with COVID-19: observational follow-up study at 3 months. Eur Geriatr Med 2021; 12: 1091&#x2013;1094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8165338</ArticleId><ArticleId IdType="pubmed">34057701</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevinsky JR, Tao G, Lavery AM, et al.. Late conditions diagnosed 1-4 months following an initial coronavirus disease 2019 (COVID-19) encounter: a matched-cohort study using inpatient and outpatient administrative data-United States, 1 March-30 June 2020. Clin Infect Dis 2021; 73(Suppl. 1): S5&#x2013;S16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135331</ArticleId><ArticleId IdType="pubmed">33909072</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra N, Chowdhury M, Singh AK, et al.. Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India. Drug Discov Ther 2021; 15: 156&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">34234065</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, et al.. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open 2021; 11: e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Faruqui S, Okoli FC, Olsen SK, et al.. Cholangiopathy after severe COVID-19: clinical features and prognostic implications. Am J Gastroenterol 2021; 116: 1414&#x2013;1425.</Citation><ArticleIdList><ArticleId IdType="pubmed">33993134</ArticleId></ArticleIdList></Reference><Reference><Citation>Faycal A, Ndoadoumgue AL, Sellem B, et al.. Prevalence and factors associated with symptom persistence: a prospective study of 429 mild COVID-19 outpatients. Infect Dis Now 2022; 52: 75&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8596656</ArticleId><ArticleId IdType="pubmed">34800742</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Mart&#xed;n-Guerrero J, Navarro-Pardo E, et al.. Gastrointestinal symptoms at the acute COVID-19 phase are risk factors for developing gastrointestinal post-COVID symptoms: a multicenter study. Intern Emerg Med 2021; 17: 583&#x2013;586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8505473</ArticleId><ArticleId IdType="pubmed">34637081</ArticleId></ArticleIdList></Reference><Reference><Citation>Galal I, Hussein AARM, Amin MT, et al.. Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score. Egypt J Bronchology 2021; 15: 10.</Citation></Reference><Reference><Citation>Galv&#xe1;n-Tejada CE, Herrera-Garc&#xed;a CF, Godina-Gonz&#xe1;lez S, et al.. Persistence of COVID-19 symptoms after recovery in Mexican population. Int J Environ Res Public Health 2020; 17: 9367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7765113</ArticleId><ArticleId IdType="pubmed">33327641</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoshal UC, Ghoshal U, Rahman MM, et al.. Post-infection functional gastrointestinal disorders following coronavirus disease-19: a case-control study. J Gastroenterol Hepatol 2022; 37: 489&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8657345</ArticleId><ArticleId IdType="pubmed">34672022</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, et al.. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens 2021; 10: 763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain MA, Hossain KMA, Saunders K, et al.. Prevalence of long COVID symptoms in Bangladesh: a prospective inception cohort study of COVID-19 survivors. BMJ Glob Health 2021; 6: e006838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8671853</ArticleId><ArticleId IdType="pubmed">34906986</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MS, Ferdous MZ, Islam US, et al.. Treatment, persistent symptoms, and depression in people infected with COVID-19 in Bangladesh. Int J Environ Res Public Health 2021; 18: 1453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7914967</ArticleId><ArticleId IdType="pubmed">33562427</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayagam JS, Jeyaraj R, Mitchell T, et al.. Patterns and prediction of liver injury with persistent cholestasis in survivors of severe SARS-CoV-2 infection. J Infect 2021; 82: e11&#x2013;e13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8019401</ArticleId><ArticleId IdType="pubmed">33826926</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones R, Davis A, Stanley B, et al.. Risk predictors and symptom features of long COVID within a broad primary care patient population including both tested and untested patients. Pragmat Obs Res 2021; 12: 93&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8366779</ArticleId><ArticleId IdType="pubmed">34408531</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F, Demircio&#x11f;lu G&#xfc;neri F, Karde&#x15f; S. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews. Rheumatol Int 2021; 41: 1263&#x2013;1271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8114015</ArticleId><ArticleId IdType="pubmed">33978818</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein H, Asseo K, Karni N, et al.. Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients. Clin Microbiol Infect 2021; 27: 769&#x2013;774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884919</ArticleId><ArticleId IdType="pubmed">33607252</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozak R, Armstrong SM, Salvant E, et al.. Recognition of long-COVID-19 patients in a Canadian tertiary hospital setting: a retrospective analysis of their clinical and laboratory characteristics. Pathogens 2021; 10: 1246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8537802</ArticleId><ArticleId IdType="pubmed">34684195</ArticleId></ArticleIdList></Reference><Reference><Citation>Leth S, Gunst JD, Mathiasen V, et al.. Persistent symptoms in patients recovering from COVID-19 in Denmark. Open Forum Infect Dis 2021; 8: ofab042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928683</ArticleId><ArticleId IdType="pubmed">33875970</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L, Yang B, Jiang N, et al.. Three-month follow-up study of survivors of coronavirus disease 2019 after discharge. J Korean Med Sci 2020; 35: e418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7721559</ArticleId><ArticleId IdType="pubmed">33289374</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardo MDM, Foppiani A, Peretti GM, et al.. Long-term coronavirus disease 2019 complications in inpatients and outpatients: a one-year follow-up cohort study. Open Forum Infect Dis 2021; 8: ofab384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8344801</ArticleId><ArticleId IdType="pubmed">34386546</ArticleId></ArticleIdList></Reference><Reference><Citation>Marasco G, Cremon C, Barbaro MR, et al.. Prevalence of gastrointestinal symptoms in severe acute respiratory syndrome coronavirus 2 infection: results of the prospective controlled multinational GI-COVID-19 study. Am J Gastroenterol 2022; 117: 147&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10337314</ArticleId><ArticleId IdType="pubmed">34751672</ArticleId></ArticleIdList></Reference><Reference><Citation>Messin L, Puyraveau M, Benabdallah Y, et al.. COVEVOL: natural evolution at 6 months of COVID-19. Viruses 2021; 13: 2151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8619893</ArticleId><ArticleId IdType="pubmed">34834958</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed-Hussein AAR, Amin MT, Makhlouf HA, et al.. Non-hospitalised COVID-19 patients have more frequent long COVID-19 symptoms. Int J Tuberc Lung Dis 2021; 25: 732&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pubmed">34802495</ArticleId></ArticleIdList></Reference><Reference><Citation>Noviello D, Costantino A, Muscatello A, et al.. Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: a controlled cohort study. Neurogastroenterol Motil 2022; 34: e14187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8209890</ArticleId><ArticleId IdType="pubmed">34060710</ArticleId></ArticleIdList></Reference><Reference><Citation>Rank A, Tzortzini A, Kling E, et al.. One year after mild COVID-19: the majority of patients maintain specific immunity, but one in four still suffer from long-term symptoms. J Clin Med 2021; 10: 3305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8347559</ArticleId><ArticleId IdType="pubmed">34362088</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizvi A, Patel Z, Liu Y, et al.. Gastrointestinal sequelae 3 and 6 months after hospitalization for coronavirus disease 2019. Clin Gastroenterol Hepatol 2021; 19: 2438&#x2013;2440.e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8245666</ArticleId><ArticleId IdType="pubmed">34217880</ArticleId></ArticleIdList></Reference><Reference><Citation>Saigal A, Naidu S, Shah A, et al.. S54 &#x2018;Long-COVID&#x2019;: the need for multi-disciplinary working. Thorax 2021; 76: A33&#x2013;A34.</Citation></Reference><Reference><Citation>Scherlinger M, Felten R, Gallais F, et al.. Refining &#x201c;Long-COVID&#x201d; by a prospective multimodal evaluation of patients with long-term symptoms attributed to SARS-CoV-2 infection. Infect Dis Ther 2021; 10: 1747&#x2013;1763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8270770</ArticleId><ArticleId IdType="pubmed">34245450</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang YF, Liu T, Yu JN, et al.. Half-year follow-up of patients recovering from severe COVID-19: analysis of symptoms and their risk factors. J Intern Med 2021; 290: 444&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242565</ArticleId><ArticleId IdType="pubmed">33904618</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoosanglertwijit R, Pitisuttithum P, Patcharatrakul T, et al.. Predictors of viral shedding in fecal samples among Coronavirus disease 2019 (COVID-19) patients and subsequent functional gastrointestinal disorders (FGIDs). J Gastroenterol Hepatol 2021; 36: 67&#x2013;68.</Citation></Reference><Reference><Citation>Salmon-Ceron D, Slama D, De Broucker T, et al.. Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: a cross-sectional study. J Infect 2021; 82: e1&#x2013;e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833274</ArticleId><ArticleId IdType="pubmed">33285216</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez-Robles M, Iguaran-Berm&#xfa;dez MDR, Garc&#xed;a-Klepizg JL, et al.. Ninety days post-hospitalization evaluation of residual COVID-19 symptoms through a phone call checklist. Pan Afr Med J 2020; 37: 289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7881918</ArticleId><ArticleId IdType="pubmed">33654513</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, et al.. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med 2021; 18: e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari B, Ghimire M, Bhatta G, et al.. Persistent symptoms in non-critical COVID-19 patients at two months follow-up in a district hospital: a descriptive cross-sectional study. JNMA J Nepal Med Assoc 2021; 59: 550&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8369569</ArticleId><ArticleId IdType="pubmed">34508406</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M, Carf&#xec; A, Martis I, et al.. Prevalence and predictors of persistence of COVID-19 symptoms in older adults: a single-center study. J Am Med Dir Assoc 2021; 22: 1840&#x2013;1844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8286874</ArticleId><ArticleId IdType="pubmed">34352201</ArticleId></ArticleIdList></Reference><Reference><Citation>Vayner Y, Lessen S, Shah R, et al.. Residual symptom burden in adult COVID-19 survivors at one, three, and six months after COVID-19 illness. Am J Respir Crit Care Med 2021; 203: A3851.</Citation></Reference><Reference><Citation>V&#xe9;lez C, Paz M, Silvernale C, et al.. Factors associated with chronic de novo post-coronavirus disease gastrointestinal disorders in a metropolitan US county. Clin Gastroenterol Hepatol 2022; 20: e1488&#x2013;e1492.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8529223</ArticleId><ArticleId IdType="pubmed">34687967</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng J, Li Y, Li J, et al.. Gastrointestinal sequelae 90 days after discharge for COVID-19. Lancet Gastroenterol Hepatol 2021; 6: 344&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7943402</ArticleId><ArticleId IdType="pubmed">33711290</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang F, Shen Y, et al.. Symptoms and health outcomes among survivors of COVID-19 infection 1 year after discharge from hospitals in Wuhan, China. JAMA Netw Open 2021; 4: e2127403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Zhang J, Zhang D, et al.. Linking the gut microbiota to persistent symptoms in survivors of COVID-19 after discharge. J Microbiol 2021; 59: 941&#x2013;948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8356893</ArticleId><ArticleId IdType="pubmed">34382150</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol 2022; 23: 194&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA. The teachings of Long COVID. Commun Med 2021; 1: 15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9053272</ArticleId><ArticleId IdType="pubmed">35602198</ArticleId></ArticleIdList></Reference><Reference><Citation>McCorkell L, Assaf GS, Davis HE, et al.. Patient-led research collaborative: embedding patients in the Long COVID narrative. Pain Rep 2021; 6: e913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8112577</ArticleId><ArticleId IdType="pubmed">33987484</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made Long Covid. Soc Sci Med 2021; 268: 113426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Guo C, Tang L, et al.. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol 2020; 5: 434&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158584</ArticleId><ArticleId IdType="pubmed">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker SJ, Mathan M, Mathan VI, et al.. Chronic enterocyte infection with coronavirus. One possible cause of the syndrome of tropical sprue? Dig Dis Sci 1982; 27: 1039&#x2013;1043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7087995</ArticleId><ArticleId IdType="pubmed">6291885</ArticleId></ArticleIdList></Reference><Reference><Citation>Settanni CR, Ianiro G, Ponziani FR, et al.. COVID-19 as a trigger of irritable bowel syndrome: a review of potential mechanisms. World J Gastroenterol 2021; 27: 7433&#x2013;7445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8613742</ArticleId><ArticleId IdType="pubmed">34887641</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, et al.. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut 2022; 71: 544&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>